CSS
QTTB icon

Cubist Systematic Strategies’s Q32 Bio QTTB Stock Holding History

Cubist Systematic Strategies’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,249
Closed -$42.1K – 3643
2024
Q4 		$42.1K Buy
+12,249
New +$387K ﹤0.01% 2796
2022
Q3 		– Sell
-1,563
Closed -$55K – 4780
2022
Q2 		$55K Buy
+1,563
New +$53.4K ﹤0.01% 4083
2022
Q1 		– Sell
-1,689
Closed -$111K – 3808
2021
Q4 		$111K Sell
1,689
-1,763
-51% -$171K ﹤0.01% 3179
2021
Q3 		$489K Buy
3,452
+588
+21% +$74.9K 0.01% 2051
2021
Q2 		$375K Buy
+2,864
New +$357K ﹤0.01% 2196
2020
Q3 		– Sell
-184
Closed -$50K – 2669
2020
Q2 		$50K Buy
+184
New +$49K ﹤0.01% 2273
2019
Q3 		– Sell
-120
Closed -$42K – 2527
2019
Q2 		$42K Buy
+120
New +$47.2K ﹤0.01% 2343

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Cubist Systematic Strategies's QTTB Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of Q32 Bio (QTTB) in Q1 2025, closing a stake of 12,249 shares — an estimated $42.1K sold.

Cubist Systematic Strategies first reported a position in QTTB in Q2 2019 and held it in 7 quarters. The position peaked at $489K in Q3 2021. 73 funds tracked by Wall St. Rank hold QTTB as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining Q32 Bio position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 12,249 Q32 Bio shares in Q1 2025, an estimated $42.1K.
  • Cubist Systematic Strategies first reported a position in Q32 Bio in Q2 2019 and held it in 7 quarters.
  • Cubist Systematic Strategies's Q32 Bio position peaked at $489K in Q3 2021.
  • 73 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.